References
- Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G, et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens. 2008 Oct;26(10):1891–900. doi:https://doi.org/10.1097/HJH.0b013e328302ca38.
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009 Oct 20;120(16):1640–45.
- Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Arch Intern Med. 2008;168:207–17.
- Khang YH, Cho SI, Kim HR. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis 2010;213:579–85. doi:https://doi.org/10.1016/j.atherosclerosis.2010.09.009.
- Cuspidi C, Sala C, Provenzano F, Tadic M, Gherbesi E, Grassi G, Mancia G. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2018;36(1):23–30. doi:https://doi.org/10.1097/HJH.0000000000001575.
- Topouchian J, Labat C, Gautier S, Bäck M, Achimastos A, Blacher J, et al. Effects of metabolic syndrome on arterial function in different age groups: the advanced approach to arterial stiffness study. J Hypertens. 2018 Apr;36(4):824–33. doi:https://doi.org/10.1097/HJH.0000000000001631.
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 practice guidelines for the management of arterial hypertension of the European society of hypertension and the European society of cardiology: ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2018;36(12):2284–309. doi:https://doi.org/10.1097/HJH.0000000000001961.
- Lacolley P, Li Z, Challande P, Regnault V. SRF/myocardin: a novel molecular axis regulating vascular smooth muscle cell stiffening in hypertension. Cardiovasc Res. 2017;113:120–22. doi:https://doi.org/10.1093/cvr/cvw253.
- Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation 2001;104:1464–70.
- Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb. 1994;14:1767–74.
- D’Elia L, Strazzullo P. Excess body weight, insulin resistance and isolated systolic hypertension: potential pathophysiological links. High Blood Press Cardiovasc Prev. 2018;25:17–23. doi:https://doi.org/10.1007/s40292-017-0240-1.
- Tomiyama H, Hirayama Y, Hashimoto H, Yambe M, Yamada J, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashinai A. The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study. Hypertens Res 2006;29:673–78.
- Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, Benetos A. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol. 2006;47(1):72–75. doi:https://doi.org/10.1016/j.jacc.2005.08.052.
- Li CI, Kardia SL, Liu CS, Lin WY, Lin CH, Lee YD, Sung F-C, Li T-C, Lin -C-C. Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study. BMC Public Health. 2011;11:808.
- Maloberti A, Bruno RM, Facchetti R, Grassi G, Taddei S, Ghiadoni L, Giannattasio C. The role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive patients. Eur J Intern Med. 2020;76:107–09.
- D’Elia L, Manfredi M, Sabino P, Strazzullo P, Galletti F. The Olivetti heart study: predictive value of a new adiposity index on risk of hypertension, blood pressure, and subclinical organ damage. Nutr Metab Cardiovasc Dis. 2016;26(7):630–36. doi:https://doi.org/10.1016/j.numecd.2016.03.009.
- D’Elia L, De Palma D, Rossi G, Strazzullo V, Russo O, Iacone R, Fazio V, Strazzullo P, Galletti F. Not smoking is associated with lower risk of hypertension: results of the Olivetti heart study. Eur J Public Health. 2014;24(2):226–30. doi:https://doi.org/10.1093/eurpub/ckt041.
- Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63(5):820‐834. doi:https://doi.org/10.1053/j.ajkd.2013.12.006.
- Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism 2008 Mar;57(3):355–61. doi:https://doi.org/10.1016/j.metabol.2007.10.010.
- Galletti F, Barbato A, Versiero M, Iacone R, Russo O, Barba G, Siani A, Cappuccio FP, Farinaro E, della Valle E, et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens. 2007 Aug;25(8):1671–77. doi:https://doi.org/10.1097/HJH.0b013e3281afa09e.
- Scuteri A, Cunha PG, Agabiti Rosei E, Badariere J, Bekaert S, Cockcroft JR, et al. MARE consortium. Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. Atherosclerosis. 2014 Apr;233(2):654–60. doi:https://doi.org/10.1016/j.atherosclerosis.2014.01.041.
- Miao R, Wu L, Ni P, Zeng Y, Chen Z. The comorbidity of increased arterial stiffness and microalbuminuria in a survey of middle-aged adults in China. BMC Cardiovasc Disord. 2018 May 4;18(1):83. doi: https://doi.org/10.1186/s12872-018-0817-1.
- Levy BI, Benessiano J, Poitevin P, Safar ME. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting enzyme inhibition. Circ Res. 1990;66:321–28. doi:https://doi.org/10.1161/01.RES.66.2.321.
- Safar ME, Asmar R, Benetos A, Blacher J, Boutouyrie P, Lacolley P, et al. Interaction between hypertension and arterial stiffness. Hypertension 2018 Oct;72(4):796–805. doi:https://doi.org/10.1161/HYPERTENSIONAHA.118.11212.
- Lacolley P, Regnault V, Avolio AP. Smooth muscle cell and arterial aging: basic and clinical aspects. Cardiovasc Res. 2018;114:513–28. doi:https://doi.org/10.1093/cvr/cvy009.
- Doronzo G, Russo I, Mattiello L, Anfossi G, Bosia A, Trovati M. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur J Clin Investig. 2004;34:664–73.
- Torjesen AA, Sigurðsson S, Westenberg JJ, Gotal JD, Bell V, Aspelund T, Launer LJ, de Roos A, Gudnason V, Harris TB, et al. Pulse pressure relation to aortic and left ventricular structure in the age, gene/environment susceptibility (AGES) - Reykjavik study. Hypertension 2014;64:756–61.
- Chung AW, Yang HH, Sigrist MK, Brin G, Chum E, Gourlay WA. Matrix metalloproteinase-2 and −9 exacerbate arterial stiffening and angiogenes is in diabetes and chronic kidney disease. Cardiovasc Res. 2009;84:494–504.
- Wautier JL, Guillausseau PJ. Diabetes, advanced glycation end-products and vascular disease. Vasc Med. 1998;3(2):131–37. doi:https://doi.org/10.1177/1358836X9800300207.
- Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994;90:42–49.
- Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despre´s J-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation. 1997;95(1):69–75. doi:https://doi.org/10.1161/01.CIR.95.1.69.
- Valdivielso P, Ramırez-Bueno A, Ewald N.Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25(8):689–94. doi:https://doi.org/10.1016/j.ejim.2014.08.008.
- Sundaram M, Curtis KR, Amir Alipour M, LeBlond ND, Margison KD, Yaworski RA, Parks RJ, McIntyre AD, Hegele RA, Fullerton MD, et al. The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation. J Lipid Res. 2017;58(11):2188–96. doi:https://doi.org/10.1194/jlr.M077313.
- D’Elia L, Giaquinto A, De Luca F, Strazzullo P, Galletti F. Relationship between circulating leptin levels and arterial stiffness: a systematic review and meta-analysis of observational studies. High Blood Press Cardiovasc Prev. 2020;27(6):505–13. doi:https://doi.org/10.1007/s40292-020-00404-y.
- Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin–angiotensin system: relationship to obesity and hypertension. J Hypertens. 2002;20(5):965–73. doi:https://doi.org/10.1097/00004872-200205000-00032.
- Cote AT, Harris KC, Panagiotopoulos C, Sandor GG, Devlin AM. Childhood obesity and cardiovascular dysfunction. J Am Coll Cardiol. 2013;62:1309–19.doi:https://doi.org/10.1016/j.jacc.2013.07.042.
- Bruijns RH, VanKleef EM, Smits JF, DeMey JG, Daemen MJ. Effects of chemical sympathectomy on angiotensin II-induced neo intimal growth in the balloon-injured rat carotid artery. J Vasc Res. 1998;35:124–33.doi:https://doi.org/10.1159/000025574.
- World Health Organization (WHO). World health organization guideline: sodium Intake for adults and children. Geneva, Switzerland: World Health Organization (WHO); 2009.
- D’Elia L, Manfredi M, Strazzullo P, Galletti F, MINISAL-SIIA Study Group. Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA study program. Eur J Clin Nutr. 2019 May;73(5):793–800. doi:https://doi.org/10.1038/s41430-018-0204-0.
- D’Elia L, Galletti F, La Fata E, Sabino P, Strazzullo P. Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials. J Hypertens. 2018;36:734–43. doi:https://doi.org/10.1097/HJH.0000000000001604.
- Zanoli L, Briet M, Empana JP, Cunha PG, Mäki-Petäjä KM, Protogerou AD, Tedgui A, Touyz RM, Schiffrin EL, Spronck B, et al. Vascular consequences of inflammation: a position statement from the ESH working group on vascular structure and function and the ARTERY society. J Hypertens. 2020 Sep;38(9):1682–98. doi:https://doi.org/10.1097/HJH.0000000000002508.
- Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension 2003;41:1000–05. doi:https://doi.org/10.1161/01.HYP.0000066844.63035.3A.
- Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E. Association between salt sensitivity and target organ damage in essential hypertension. Am J Hypertens. 2000 Aug;13(8):864–72. doi:https://doi.org/10.1016/S0895-7061(00)00253-3.
- Ait-Oufella H, Sage AP, Mallat Z, Tedgui A. Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res. 2014;114:1640–60. doi:https://doi.org/10.1161/CIRCRESAHA.114.302761.
- Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharmacol. 2019;176:1818–182. doi:https://doi.org/10.1111/bph.14427.
- Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II. NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal. 2013;19:1110–20. doi:https://doi.org/10.1089/ars.2012.4641.
- Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley A, Lowe GDO, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35(9):578–89. doi:https://doi.org/10.1093/eurheartj/eht367.
- Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998;47(8):929–33. doi:https://doi.org/10.1016/S0026-0495(98)90346-8.
- Bombelli M, Quarti-Trevano F, Tadic M, Facchetti R, Cuspidi C, Mancia G, Grassi G. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni arteriose monitorate E Loro Associazioni study. J Hypertens. 2018 Jul;36(7):1492–98. doi:https://doi.org/10.1097/HJH.0000000000001721.
- Canepa M, Viazzi F, Strait JB, Ameri P, Pontremoli R, Brunelli C, Studenski S, Ferrucci L, Lakatta EG, AlGhatrif M. Longitudinal association between serum uric acid and arterial stiffness: results from the baltimore longitudinal study of aging. Hypertension 2017 Feb;69(2):228–35. doi:https://doi.org/10.1161/HYPERTENSIONAHA.116.08114.
- Russo E, Drovandi S, Salvidio G, Verzola D, Esposito P, Garibotto G, Viazzi F. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy. Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2343–50. doi:https://doi.org/10.1016/j.numecd.2020.07.038.
- Rebora P, Andreano A, Triglione N, Piccinelli E, Palazzini M, Occhi L, Grassi G, Valsecchi MG, Giannattasio C, Maloberti A. Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis. Blood Press. 2020 Aug;29(4):220–31. doi:https://doi.org/10.1080/08037051.2020.1735929.
- Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26:269–75. doi:https://doi.org/10.1097/HJH.0b013e3282f240bf.
- Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553–62. doi:https://doi.org/10.1681/ASN.2005050572.
- Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid: a facet of hyperinsulinemia. Diabetologia 1987;30:713–18. doi:https://doi.org/10.1007/BF00296994.
- D’Elia L, Giaquinto A, Cappuccio FP, Iacone R, Russo O, Strazzullo P, Galletti F. Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men. J Endocrinol Invest. 2020;43(5):587–93. doi:https://doi.org/10.1007/s40618-019-01140-4.
- Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J. Reference values for clinic pulse pressure in a nonselected population. Am J Hypertens. 2001;14:415–18. doi:https://doi.org/10.1016/S0895-7061(01)01284-5.
- Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001;104(7):783–89. doi:https://doi.org/10.1161/hc3201.094227.
- Ting CT, Chen CH, Chang MS, Yin FC. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertension 1995;26:524–30. doi:https://doi.org/10.1161/01.HYP.26.3.524.
- D’Elia L, La Fata E, Iannuzzi A, Rubba PO. Effect of statin therapy on pulse wave velocity: a meta-analysis of randomized controlled trials. Clin Exp Hypertens. 2018;40(7):601–08. doi:https://doi.org/10.1080/10641963.2017.1411498.
- Meaney E, Vela A, Samaniego V, Meaney A, Asbún J, Zempoalteca JC,et al. Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study. Clin Exp Pharmacol Physiol. 2008;35(8):895–903. doi:https://doi.org/10.1111/j.1440-1681.2008.04920.x.